Literature DB >> 5002799

Selective blockade of the vasodepressor response to prostaglandin F 2 in the anaesthetized rabbit.

B Levy, H R Lindner.   

Abstract

1. The prostaglandin-blocking activity of meclofenamic acid, N-(2,6-dichloro-m-tolyl)anthranilic acid (CI-583), was analysed in the anaesthetized rabbit. PGF(2alpha), PGE(1) and isoprenaline were injected before and after meclofenamic acid infusion.2. Isoprenaline produced a fall in blood pressure, a reduction in oviduct motility and a reduction in uterine motility if the uterus showed marked spontaneous motility. PGF(2alpha) uniformly produced a fall in blood pressure and an increase in both uterine and oviduct contractility. PGE(1) produced a fall in blood pressure, a reduction in oviduct motility and no consistent effect on uterine motility.3. Meclofenamic acid selectively blocked the vasodepressor response to PGF(2alpha). The vasodepressor responses to PGE(1) and isoprenaline as well as the effects of all three agonists on uterine and oviduct contractility were not reduced by treatment with meclofenamic acid.4. Polyphloretin phosphate (PPP) administered to two rabbits in a cumulative dose of 94 mg/kg showed no significant blocking action on the vasodepressor or uterine and oviduct contractor responses to PGE(1) or PGF(2alpha) though this compound, like meclofenamic acid, has been reported to antagonize the actions of PGE(1) and PGF(2alpha) on isolated smooth muscle preparations.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5002799      PMCID: PMC1665927          DOI: 10.1111/j.1476-5381.1971.tb07172.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  A COMPARISON OF THE ACTIONS OF PROSTAGLANDINS F2-ALPHA AND E1 ON SMOOTH MUSCLE.

Authors:  E W HORTON; I H MAIN
Journal:  Br J Pharmacol Chemother       Date:  1965-04

2.  The nature of the prostaglandin-blocking activity of polyphloretin phosphate.

Authors:  K E Eakins; J D Miller; S M Karim
Journal:  J Pharmacol Exp Ther       Date:  1971-02       Impact factor: 4.030

3.  Prostaglandin antagonists: synthesis and smooth muscle activity.

Authors:  J Fried; T S Santhanakrishnan; J Himizu; C H Lin; S H Ford; B Rubin; E O Grigas
Journal:  Nature       Date:  1969-07-12       Impact factor: 49.962

4.  Blockade by polyphloretin phosphate of the prostaglandin F2a action on isolated human bronchi.

Authors:  A A Mathé; K Strandberg; A Aström
Journal:  Nat New Biol       Date:  1971-04-14

5.  Antagonism of prostaglandin E2 by 1-acetyl-2-(8-chloro-10,11-dihydrodibenz (b,f) (1,4) oxazepine-10-carbonyl) hydrazine (SC-19220).

Authors:  J H Sanner
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-07

6.  Distribution and function of adrenergic nerves in the rabbit fallopian tube.

Authors:  J Brundin
Journal:  Acta Physiol Scand Suppl       Date:  1965

7.  Tachyphylaxis in rat uterus to some prostaglandins.

Authors:  U Adamson; R Eliasson; B Wiklund
Journal:  Acta Physiol Scand       Date:  1967 Jul-Aug

8.  Antagonism of some smooth muscle actions of prostaglandins by polyphloretin phosphate.

Authors:  K E Eakins; S M Karim; J D Miller
Journal:  Br J Pharmacol       Date:  1970-07       Impact factor: 8.739

  8 in total
  4 in total

1.  Sodium flufenamate antagonises the potentiation by prostaglandins of noradrenaline-induced vasoconstriction in rat mesentery [proceedings].

Authors:  A Bennett; M A Carroll; G J Sanger
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

2.  Mechanisms of reflex bradycardia and hypotension by metabolites of arachidonic acid in the cat.

Authors:  T H Hintze; G Kaley; M J Panzenbeck
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

3.  Antagonism by fenamates of prostaglandin action in guinea-pig and human alimentary muscle.

Authors:  A Bennett; D Pratt; G J Sanger
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

4.  Fenamates may antagonize the actions of prostaglandin endoperoxides in human myometrium.

Authors:  G J Sanger; A Bennett
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.